It is a pharma private limited company based in Pune, Maharashtra, India, established in 1982.
1982 | Pune, Maharashtra, India | ActiveSelegance Pharma Pvt Ltd, a active private limited company, was established on 29 July 1982 in Pune, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U52311MH1982PTC027896. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Swati Sachin Natekar (Director), Makarand Madhukar Tilloo (Director), Mrunal Mohan Tilloo (Director). Past directors included Sharad Sadashiv Tilloo, Saroj Madhukar Tilloo. It holds ₹0.65 M open charges and ₹2.24 M settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at 647 Kasba Pethmanic Chowk, Pune, Maharashtra, 411011.
U52311MH1982PTC027896
027896
29 July 1982
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Selegance Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swati Sachin Natekar | Director | 01 Jul 2021 | Current |
| Makarand Madhukar Tilloo | Director | 01 Sep 1989 | Current |
| Mrunal Mohan Tilloo | Director | 01 Oct 2013 | Current |
| Subhash Sharad Tilloo | Director | 29 Jul 1982 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Feb 2020 | Past |
| Pramod Abcsdd | Director | 01 Oct 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Selegance Pharma Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.42% decrease. The company also saw a substantial fall in profitability, with a 60.33% decrease in profit. The company's net worth moved up by a moderate rise of 5.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Selegance Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹650,000.00
₹2,240,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2017 | Others | ₹1.50 M | Satisfied |
| 31 Mar 2001 | The Cosmos Co-Operative Bank Ltd | ₹0.65 M | Satisfied |
| 26 Jun 1986 | The Cosmos Cooperative Bank Ltd. | ₹0.09 M | Satisfied |
Explore comprehensive loan charge details -
Selegance Pharma has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Selegance Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Selegance Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 31 Mar 2001 via Charge ID 90085741 with The Cosmos Co-Operative Bank Ltd was fully satisfied on 07 Jan 2025. was documented.
Progress on Selegance Pharma Pvt Ltd last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.
The activity A charge registered on 26 Jun 1986 via Charge ID 90083433 with The Cosmos Cooperative Bank Ltd. was fully satisfied on 18 Jun 2024. was completed.
The activity Selegance Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Swati Sachin Natekar was appointed as a Director was appointed as a Director on 01 Jul 2021 & has been associated with this company since 4 years 5 months . was documented.
A charge registered on 20 Jan 2017 via Charge ID 100080687 with Others was fully satisfied on 05 Feb 2021. was recorded as a recent event.
The CIN of Selegance Pharma Pvt Ltd is U52311MH1982PTC027896.
Selegance Pharma Pvt Ltd is headquartered at 647 Kasba Pethmanic Chowk, Pune, Maharashtra, 411011.
Selegance Pharma Pvt Ltd was incorporated on 29 July 1982.
The current directors of Selegance Pharma Pvt Ltd are
The primary industry of Selegance Pharma Pvt Ltd is Manufacturing.
Selegance Pharma Pvt Ltd is unlisted.
The authorized capital of Selegance Pharma Pvt Ltd is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Selegance Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX